Tangtingtung investigator-assessed PFS per RECIST Cotbolon
USA
Entertainment
+916127027194
frenzinaomi@gmail.com
Added on 12 Apr 2025
2038 Jewell Road
Business Description
FDA approval for the treatment of unresectable or metastatic, hormone receptor–positive breast cancer with HER2-low (IHC 1+ or 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) expression, as determined by an FDA-approved test, in patients who have experienced disease progression on 1 or more prior lines of endocrine therapy in the metastatic setting.1
This regulatory decision was supported by findings from the phase 3 DESTINY-Breast06 trial (NCT04494425), in which treatment with T-DXd generated a 36% reduction in the risk of disease progression or death compared with chemotherapy (HR, 0.64; 95% CI, 0.54-0.76; P < .0001) in the overall population of patients with chemotherapy-naive HER2-low -ultralow metastatic breast cancer.1,2 The median progression-free survival (PFS) was 13.2 months (95% CI, 12.0-15.2) with T-DXd vs 8.1 months (95% CI, 7.0-9.0) with chemotherapy. Additionally, the confirmed overall response rate (ORR) was 62.6% with T-DXd compared with 34.4% with chemotherapy.
“Endocrine therapy is typically used in the initial treatment of hormone receptor–positive metastatic breast cancer, and following progression, subsequent chemotherapy is associated with poor outcomes," Aditya Bardia, MD, MPH, program director of Breast Oncology and director of Translational Research Integration at the UCLA Health Jonsson Comprehensive Cancer Center, as well as the lead study author of the DESTINY-Breast06 trial, stated in a news release.1 "With a median PFS exceeding 1 year and [an ORR of 62.6%], T-DXd offers a potential new standard of care for patients with hormone receptor–positive, HER2-low or HER2-ultralow metastatic breast cancer following endocrine therapy.”
The multicenter, open-label DESTINY-Breast06 trial enrolled patients with hormone receptor–positive metastatic breast cancer with low HER2 expression (defined as IHC 1+ or 2+ and negative ISH results) or ultralow HER2 expression (defined as IHC 0 with no membrane staining) who had previously received at least 1 line of endocrine-based therapy and had no history of chemotherapy for metastatic breast cancer.2 Patients were randomly assigned 1:1 to receive T-DXd or physician's choice of chemotherapy. PFS among patients with HER2-loe disease served as the primary end point. Secondary end points included PFS among all randomly assigned patients, overall survival (OS), and safety.
https://wall.famewall.io/una-pelicula-de-minecraft-online-en-espanol
https://wall.famewall.io/ver-mala-influencia-online-en-espanol
https://wall.famewall.io/a-complete-unknown-online-en-espanol
https://wall.famewall.io/memorias-de-un-caracol-online-en-espanol
https://wall.famewall.io/culpa-mia-londres-online-en-espanol
https://wall.famewall.io/pideme-lo-que-quieras-online-en-espanol
https://wall.famewall.io/blancanieves-online-en-espanol
https://wall.famewall.io/the-brutalist-online-en-espanol
https://wall.famewall.io/mickey-17-online-en-espanol
https://wall.famewall.io/vermiglio-online-en-espanol
https://wall.famewall.io/la-sustancia-online-en-espanol
https://wall.famewall.io/contraataque-online-en-espanol
https://wall.famewall.io/el-abismo-secreto-online-en-espanol
https://wall.famewall.io/polican-online-en-espanol
https://wall.famewall.io/sidelined-the-qb-and-me-online-en-espanol
Frequently Asked Questions
➤ What services does Tangtingtung investigator-assessed PFS per RECIST Cotbolon offer?
Tangtingtung investigator-assessed PFS per RECIST Cotbolon provides professional Entertainment services for customers in USA, . They focus on delivering quality solutions tailored to client needs.
➤ Where is Tangtingtung investigator-assessed PFS per RECIST Cotbolon located?
This business is located in USA, , making it a convenient choice for local customers looking for reliable Entertainment services.
➤ How can I contact Tangtingtung investigator-assessed PFS per RECIST Cotbolon?
You can contact Tangtingtung investigator-assessed PFS per RECIST Cotbolon via phone or email listed on this page to learn more about their services and availability.
➤ Why choose Tangtingtung investigator-assessed PFS per RECIST Cotbolon over other Entertainment providers?
Tangtingtung investigator-assessed PFS per RECIST Cotbolon is known for professionalism, customer satisfaction, and dependable service, making it a trusted choice for Entertainment needs in USA.
Services Offered by Tangtingtung investigator-assessed PFS per RECIST Cotbolon
Tangtingtung investigator-assessed PFS per RECIST Cotbolon provides a range of Entertainment services designed to meet customer needs efficiently. Their services are tailored for individuals and businesses seeking reliable and professional support.
- Professional Entertainment consultation
- Customer-focused service approach
- Affordable and transparent pricing
- Timely project delivery
Business Hours
This business typically operates during standard working hours. Customers are encouraged to contact the business directly to confirm current availability and service timings.
Customer Support
Tangtingtung investigator-assessed PFS per RECIST Cotbolon values customer satisfaction and provides dedicated support to address inquiries and service requests. Their team ensures a smooth experience from initial contact to service completion.
Local USA Business Information
Tangtingtung investigator-assessed PFS per RECIST Cotbolon proudly serves customers in USA, . As a local business, it understands the needs of the community and provides services that align with regional requirements.
